Cargando…

Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression

Merkel cell carcinoma is a rare and aggressive primary neuroendocrine carcinoma of the skin, whose pathogenesis can be traced back to UV radiation damage or Merkel cell polyomavirus (MCPyV) infection. Despite some improvements on the characterization of the disease partly due to its increased incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Federica, Maletta, Francesca, Parente, Renato, Fissore, Jessica, Tampieri, Cristian, Santoro, Leonardo, Birocco, Nadia, Picciotto, Franco, Quaglino, Pietro, Volante, Marco, Asioli, Sofia, Senetta, Rebecca, Papotti, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135831/
https://www.ncbi.nlm.nih.gov/pubmed/35551625
http://dx.doi.org/10.1007/s12022-022-09716-2
_version_ 1784714049659863040
author Santoro, Federica
Maletta, Francesca
Parente, Renato
Fissore, Jessica
Tampieri, Cristian
Santoro, Leonardo
Birocco, Nadia
Picciotto, Franco
Quaglino, Pietro
Volante, Marco
Asioli, Sofia
Senetta, Rebecca
Papotti, Mauro
author_facet Santoro, Federica
Maletta, Francesca
Parente, Renato
Fissore, Jessica
Tampieri, Cristian
Santoro, Leonardo
Birocco, Nadia
Picciotto, Franco
Quaglino, Pietro
Volante, Marco
Asioli, Sofia
Senetta, Rebecca
Papotti, Mauro
author_sort Santoro, Federica
collection PubMed
description Merkel cell carcinoma is a rare and aggressive primary neuroendocrine carcinoma of the skin, whose pathogenesis can be traced back to UV radiation damage or Merkel cell polyomavirus (MCPyV) infection. Despite some improvements on the characterization of the disease partly due to its increased incidence, crucial pathogenetic and prognostic factors still need to be refined. A consecutive series of 228 MCC from three hospitals in Turin was collected with the aim of both analyzing the apparent increase in MCC incidence in our area and investigating the distribution and prognostic role of clinical-pathological parameters, with a focus on MCPyV status, ALK tumor expression and tumor infiltrating lymphocytes (TILs). Review of morphology and conventional immunohistochemical staining was possible in 191 cases. In 50 cases, the expression of the novel neuroendocrine marker INSM1 was additionally assessed. Fourteen cases of MCC of unknown primary skin lesion were identified and separately analyzed. While confirming an exponential trend in MCC incidence in the last decades and providing a description of histological and cytological features of a large series of MCC, the present study concludes that 1) INSM1 is a highly sensitive marker in both skin and lymph node primary MCC; 2) positive MCPyV status, brisk TILs and lower tumor size and thickness are independent positive prognostic parameters, and the combination of the former two may provide a novel tool for prognostic stratification; 3) ALK is expressed 87% of MCC and associated with positive viral status, and could represent a prognostic biomarker, if validated in larger series.
format Online
Article
Text
id pubmed-9135831
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-91358312022-05-28 Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression Santoro, Federica Maletta, Francesca Parente, Renato Fissore, Jessica Tampieri, Cristian Santoro, Leonardo Birocco, Nadia Picciotto, Franco Quaglino, Pietro Volante, Marco Asioli, Sofia Senetta, Rebecca Papotti, Mauro Endocr Pathol Article Merkel cell carcinoma is a rare and aggressive primary neuroendocrine carcinoma of the skin, whose pathogenesis can be traced back to UV radiation damage or Merkel cell polyomavirus (MCPyV) infection. Despite some improvements on the characterization of the disease partly due to its increased incidence, crucial pathogenetic and prognostic factors still need to be refined. A consecutive series of 228 MCC from three hospitals in Turin was collected with the aim of both analyzing the apparent increase in MCC incidence in our area and investigating the distribution and prognostic role of clinical-pathological parameters, with a focus on MCPyV status, ALK tumor expression and tumor infiltrating lymphocytes (TILs). Review of morphology and conventional immunohistochemical staining was possible in 191 cases. In 50 cases, the expression of the novel neuroendocrine marker INSM1 was additionally assessed. Fourteen cases of MCC of unknown primary skin lesion were identified and separately analyzed. While confirming an exponential trend in MCC incidence in the last decades and providing a description of histological and cytological features of a large series of MCC, the present study concludes that 1) INSM1 is a highly sensitive marker in both skin and lymph node primary MCC; 2) positive MCPyV status, brisk TILs and lower tumor size and thickness are independent positive prognostic parameters, and the combination of the former two may provide a novel tool for prognostic stratification; 3) ALK is expressed 87% of MCC and associated with positive viral status, and could represent a prognostic biomarker, if validated in larger series. Springer US 2022-05-12 2022 /pmc/articles/PMC9135831/ /pubmed/35551625 http://dx.doi.org/10.1007/s12022-022-09716-2 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Santoro, Federica
Maletta, Francesca
Parente, Renato
Fissore, Jessica
Tampieri, Cristian
Santoro, Leonardo
Birocco, Nadia
Picciotto, Franco
Quaglino, Pietro
Volante, Marco
Asioli, Sofia
Senetta, Rebecca
Papotti, Mauro
Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
title Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
title_full Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
title_fullStr Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
title_full_unstemmed Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
title_short Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression
title_sort clinical-pathological evaluation and prognostic analysis of 228 merkel cell carcinomas focusing on tumor-infiltrating lymphocytes, mcpyv infection and alk expression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135831/
https://www.ncbi.nlm.nih.gov/pubmed/35551625
http://dx.doi.org/10.1007/s12022-022-09716-2
work_keys_str_mv AT santorofederica clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT malettafrancesca clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT parenterenato clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT fissorejessica clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT tampiericristian clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT santoroleonardo clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT birocconadia clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT picciottofranco clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT quaglinopietro clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT volantemarco clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT asiolisofia clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT senettarebecca clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression
AT papottimauro clinicalpathologicalevaluationandprognosticanalysisof228merkelcellcarcinomasfocusingontumorinfiltratinglymphocytesmcpyvinfectionandalkexpression